|
Originally published In Press as doi:10.1074/jbc.M608458200 on February 11, 2007
J. Biol. Chem., Vol. 282, Issue 16, 11676-11686, April 20, 2007
Function, Activity, and Membrane Targeting of Cytosolic Phospholipase A2 in Mouse Lung Fibroblasts*
Moumita Ghosh ,
Robyn Loper ,
Farideh Ghomashchi ,
Dawn E. Tucker ,
Joseph V. Bonventre¶,
Michael H. Gelb , and
Christina C. Leslie ||1
From the
Program in Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado 80206, the Departments of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, the ¶Renal Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, and the ||Departments of Pathology and Pharmacology, University of Colorado School of Medicine, Aurora, Colorado 80045
Group IVA cytosolic phospholipase A2 (cPLA2 ) initiates eicosanoid production; however, this pathway is not completely ablated in cPLA2 / lung fibroblasts stimulated with A23187
[GenBank]
or serum. cPLA2 +/+ fibroblasts preferentially released arachidonic acid, but A23187
[GenBank]
-stimulated cPLA2 / fibroblasts nonspecifically released multiple fatty acids. Arachidonic acid release from cPLA2 / fibroblasts was inhibited by the cPLA2 inhibitors pyrrolidine-2 (IC50, 0.03 µM) and Wyeth-1 (IC50, 0.1 µM), implicating another C2 domain-containing group IV PLA2. cPLA2 / fibroblasts contain cPLA2 and cPLA2 but not cPLA2 or cPLA2 . Purified cPLA2 exhibited much higher lysophospholipase and PLA2 activity than cPLA2 and was potently inhibited by pyrrolidine-2 and Wyeth-1, which did not inhibit cPLA2 . In contrast to cPLA2 , cPLA2 expressed in Sf9 cells mediated A23187
[GenBank]
-induced arachidonic acid release, which was inhibited by pyrrolidine-2 and Wyeth-1. cPLA2 exhibits specific activity, inhibitor sensitivity, and low micromolar calcium dependence similar to cPLA2 and has been identified as the PLA2 responsible for calcium-induced fatty acid release and prostaglandin E2 production from cPLA2 / lung fibroblasts. In response to ionomycin, EGFP-cPLA2 translocated to ruffles and dynamic vesicular structures, whereas EGFP-cPLA2 translocated to the Golgi and endoplasmic reticulum, suggesting distinct mechanisms of regulation for the two enzymes.
Received for publication, September 4, 2006
, and in revised form, January 19, 2007.
* This work was supported by National Institutes of Health Grants HL61378 and HL34303 (to C. C. L.) and HL50040 (to M. H. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains Supplemental Movie 1.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) DQ888308
[GenBank]
and DQ904008
[GenBank]
.
1 To whom correspondence should be addressed: Dept. of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206. Tel.: 303-398-1214; Fax: 303-270-2155; E-mail: lesliec{at}njc.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Yuan, R. S. Sidhu, D. V. Kuklev, Y. Kado, M. Wada, I. Song, and W. L. Smith
Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers
J. Biol. Chem.,
April 10, 2009;
284(15):
10046 - 10055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gubern, J. Casas, M. Barcelo-Torns, D. Barneda, X. de la Rosa, R. Masgrau, F. Picatoste, J. Balsinde, M. A. Balboa, and E. Claro
Group IVA Phospholipase A2 Is Necessary for the Biogenesis of Lipid Droplets
J. Biol. Chem.,
October 10, 2008;
283(41):
27369 - 27382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Green, S. K. Orr, and R. P. Bazinet
The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids
J. Lipid Res.,
May 1, 2008;
49(5):
939 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cubells, S. V. de Muga, F. Tebar, J. V. Bonventre, J. Balsinde, A. Pol, T. Grewal, and C. Enrich
Annexin A6-induced Inhibition of Cytoplasmic Phospholipase A2 Is Linked to Caveolin-1 Export from the Golgi
J. Biol. Chem.,
April 11, 2008;
283(15):
10174 - 10183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Graf, B. Zemann, P. Rovina, N. Urtz, A. Schanzer, R. Reuschel, D. Mechtcheriakova, M. Muller, E. Fischer, C. Reichel, et al.
Neutropenia with Impaired Immune Response to Streptococcus pneumoniae in Ceramide Kinase-Deficient Mice
J. Immunol.,
March 1, 2008;
180(5):
3457 - 3466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wada, C. J. DeLong, Y. H. Hong, C. J. Rieke, I. Song, R. S. Sidhu, C. Yuan, M. Warnock, A. H. Schmaier, C. Yokoyama, et al.
Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-derived Versus Eicosapentaenoic Acid-derived Substrates and Products
J. Biol. Chem.,
August 3, 2007;
282(31):
22254 - 22266.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|